Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular procedures
Year: 2006
Type: review
DOI: 10.1002/ccd.20964
Authors: Marc J. Schweiger, Charles E. Chambers, Charles J. Davidson, Shaoheng Zhang, James Blankenship, Narinder P. Bhalla, Peter C. Block, John P. Dervan, Christine Gasperetti, Lowell Gerber, Neal S. Kleiman, Ronald J. Krone, William J. Phillips, Robert M. Siegel, Barry F. Uretsky, Warren K. Laskey
Institutions: Tufts University, Baystate Medical Center, Baystate Health, Pennsylvania State University, Northwestern University, Fudan University, Geisinger Medical Center, Carilion Roanoke Memorial Hospital, Emory University, Stony Brook University Hospital, Stony Brook Medicine, Deborah Heart and Lung Center, Community Health Systems - Northeast Regional Medical Center, Baylor College of Medicine, Washington University in St. Louis, Central Maine Medical Center, The University of Texas Medical Branch at Galveston, University of New Mexico
Language: English
Topic: Acute Kidney Injury Research
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: contrast-induced nephropathy, prevention, high-risk patients, cardiovascular procedures, chronic kidney disease, estimated glomerular filtration rate, hydration, nephrotoxic agents, N-acetylcysteine, low-osmolar contrast agents, contrast volume reduction, metformin, nonsteroidal anti-inflammatory drugs, acute kidney injury
Open Access status: closed
OpenAlex ID: W2021396997
